GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gongwin Biopharm Holdings Co Ltd (ROCO:6617) » Definitions » Short-Term Capital Lease Obligation

Gongwin Biopharm Holdings Co (ROCO:6617) Short-Term Capital Lease Obligation : NT$0.87 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Gongwin Biopharm Holdings Co Short-Term Capital Lease Obligation?

Gongwin Biopharm Holdings Co's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was NT$0.87 Mil.

Gongwin Biopharm Holdings Co's quarterly Short-Term Capital Lease Obligation declined from Sep. 2023 (NT$3.36 Mil) to Dec. 2023 (NT$2.12 Mil) and declined from Dec. 2023 (NT$2.12 Mil) to Mar. 2024 (NT$0.87 Mil).

Gongwin Biopharm Holdings Co's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (NT$1.99 Mil) to Dec. 2022 (NT$5.01 Mil) but then declined from Dec. 2022 (NT$5.01 Mil) to Dec. 2023 (NT$2.12 Mil).


Gongwin Biopharm Holdings Co Short-Term Capital Lease Obligation Historical Data

The historical data trend for Gongwin Biopharm Holdings Co's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gongwin Biopharm Holdings Co Short-Term Capital Lease Obligation Chart

Gongwin Biopharm Holdings Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.85 4.70 1.99 5.01 2.12

Gongwin Biopharm Holdings Co Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4.59 3.36 2.12 0.87

Gongwin Biopharm Holdings Co Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


Gongwin Biopharm Holdings Co Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Gongwin Biopharm Holdings Co's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Gongwin Biopharm Holdings Co (ROCO:6617) Business Description

Traded in Other Exchanges
N/A
Address
3rd Floor, No.80, Jianguo North Road, Section 1, Zongshan District, Taipei, TWN, 10491
Gongwin Biopharm Holdings Co Ltd is a Taiwanese biotech and pharmaceutical company engaged in research and development of anti-cancer drugs. The company develops products related to central lung serious tracheal obstruction, primary liver cancer, malignant pleural effusion, and tracheal adenoid cystic carcinoma.

Gongwin Biopharm Holdings Co (ROCO:6617) Headlines

No Headlines